Fundraising FoxExPrimary
Rockville, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into ExPrimary
Sign up to see every warm intro you have to ExPrimary
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ExPrimary team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Exprimary develops bioanalytical instrumentation and assay products at reduced cost for research and diagnostic markets. The company focuses on enabling personalized healthcare by improving access to bioanalysis tools globally.
Founders & leadership
SH
Sean HigginsExecutive
HA
Holly AtleeExecutive
SS
Scott StelickNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$80K disclosed across 3 rounds · 2016–2018
▶$35KraisedJan 2022 · 3 investors · BiotechnologyRule 506(b)
▶$35KraisedJan 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sean HigginsExecutive Officer, Director
- Holly AtleeExecutive Officer
- Scott StelickExecutive Officer
- Offering amount
- $750K
- Amount sold
- $35K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10KraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$10KraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott StelickExecutive Officer
- Holly AtleeExecutive Officer
- Sean HigginsExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $10K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$35KraisedNov 2016 · 1 investors · BiotechnologyRule 506(b)
▶$35KraisedNov 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sean HigginsExecutive Officer, Director
- Holly AtleeExecutive Officer
- Scott StelickExecutive Officer
- Offering amount
- $65K
- Amount sold
- $35K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does ExPrimary do?
- Exprimary develops bioanalytical instrumentation and assay products at reduced cost for research and diagnostic markets. The company focuses on enabling personalized healthcare by improving access to bioanalysis tools globally.
- Who are ExPrimary's investors?
- ExPrimary's investors include The Innovation Space.
- How much funding has ExPrimary raised?
- ExPrimary has disclosed $80K raised across 3 rounds.
- Where is ExPrimary headquartered?
- ExPrimary is headquartered in Rockville, US.